Obalon Therapeutics, Inc. announced that Jonah Shacknai, Executive Chairman of DermaForce and former Chairman and Chief Executive Officer of Medicis has been elected to its board of directors.  Mr. Shacknai joins Raymond Dittamore and Les Howe as the latest members of Obalon Therapeutic’s board of directors. Mr. Shacknai is currently the Executive Chairman of DermaForce Partners.   Previously, Mr. Shacknai was the founder of Medicis Pharmaceutical Corporation, and served as its Chairman and Chief Executive Officer for 25 years, until the acquisition of the Company in 2012 for $2.6 billion. Mr. Shacknai joins the board as the newest member, following Raymond Dittamore and Les Howe joining in 2016. Mr. Dittamore retired as a partner of Ernst & Young LLP in 2001 after 35 years of service. Mr. Dittamore currently serves on the board of directors of QUALCOMM Incorporated.  Mr. Dittamore previously served as a director of Life Technologies Corporation from July 2001 to February 2014, Gen-Probe Incorporated from August 2002 to September 2009 and Digirad Corporation from March 2004 to March 2008.